Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis

NCT00979654 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT00979654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00979654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Open-label Study to Evaluate the Long-term Safety of Sifalimumab in Adult Subjects With Systemic Lupus Erythematosus or Myositis
Lead sponsor
MedImmune LLC
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2010
Completion date
March 31, 2015
Enrollment
118 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus